These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2890669)

  • 1. Hemodynamic effects during rest and exercise of bucindolol in hypertensive men.
    Conner DP; Vlasses PH; Clementi RA; Oren A; Deitchman D; Ferguson RK
    J Clin Pharmacol; 1987 Apr; 27(4):300-3. PubMed ID: 2890669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative beta-adrenoceptor blocking effect and pharmacokinetics of bucindolol and propranolol in man.
    Maury M; Berdeaux A; Kher A; Duhaze P; Giudicelli JF
    Eur J Clin Pharmacol; 1985; 27(6):649-56. PubMed ID: 2859199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of bucindolol in systemic hypertension.
    Kimura S; DeQuattro V; Edmiston WA; Loo R; Thien S; Rigonan K; Deitchman D; Foti A
    Am J Cardiol; 1987 Nov; 60(13):1083-6. PubMed ID: 2890292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
    Gilbert EM; Anderson JL; Deitchman D; Yanowitz FG; O'Connell JB; Renlund DG; Bartholomew M; Mealey PC; Larrabee P; Bristow MR
    Am J Med; 1990 Mar; 88(3):223-9. PubMed ID: 1968710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
    O'Connor PC; Finch MJ; Harron DW; Meredith PA; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
    Wendt T; van der Does R; Schräder R; Landgraf H; Kober G
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients.
    Eggertsen R; Sivertsson R; Andrén L; Hansson L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S97-100. PubMed ID: 2454378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension.
    Rotmensch HH; Rocci ML; Vlasses PH; Swanson BN; Fedder IL; Soyka L; Ferguson RK
    Am J Cardiol; 1984 Aug; 54(3):353-6. PubMed ID: 6147080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.
    Ades PA; Wolfel EE; Hiatt WR; Fee C; Rolfs R; Brammell HL; Horwitz LD
    Eur J Clin Pharmacol; 1989; 36(1):5-10. PubMed ID: 2917588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
    Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
    J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and energetic comparison of bucindolol and metoprolol for the treatment of congestive heart failure.
    Heesch CM; Marcoux L; Hatfield B; Eichhorn EJ
    Am J Cardiol; 1995 Feb; 75(5):360-4. PubMed ID: 7856528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects.
    Cournot A; Lim C; Duchier J; Safar M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S35-9. PubMed ID: 1378147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of single doses of bucindolol and oxprenolol in hypertensive patients.
    Webster J; Petrie JC; Robb OJ; Jamieson M; Verschueren J
    Br J Clin Pharmacol; 1985 Oct; 20(4):393-400. PubMed ID: 2866786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic properties of bucindolol, a beta-adrenoreceptor blocking drug with vasodilator activity.
    Bett N; Dryburgh L; Boyle C; Hawley C
    Am J Cardiol; 1986 Mar; 57(8):678-81. PubMed ID: 2869679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of beta-adrenoceptor blocking agents in hypertension. A comparison between metoprolol and pindolol with special reference to peripheral vascular effects.
    Svensson A; Gudbrandsson T; Sivertsson R; Hansson L
    Acta Med Scand Suppl; 1982; 665():103-8. PubMed ID: 6760678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive mechanism of beta-adrenoceptor antagonism--the role of beta 2-blockade.
    Dahlöf B; Andrén L; Svensson A; Hansson L
    J Hypertens Suppl; 1983 Dec; 1(2):112-5. PubMed ID: 6152739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension.
    Eggertsen R; Sivertsson R; Andrén L; Hansson L
    J Hypertens; 1984 Oct; 2(5):529-34. PubMed ID: 6152280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral hemodynamic effects of short-term nadolol administration in essential hypertension.
    Levenson J; Simon AC; Moyse D; Bouthier J; Safar ME
    Am Heart J; 1984 Oct; 108(4 Pt 2):1177-82. PubMed ID: 6148882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.